Safety and immunogenicity of 13-Valent pneumococcal conjugate vaccine in healthy infants in Shanghai during the COVID-19 pandemic: a prospective cohort study

BackgroundStreptococcus pneumoniae (S. pneumoniae) is a major cause of morbidity and mortality in infants, leading to diseases like pneumonia and otitis media. Although the World Health Organization (WHO) recommends inclusion of pneumococcal conjugate vaccines (PCVs) in national immunization program...

Cijeli opis

Bibliografski detalji

Glavni autori:	Lijing Xin, Liang Hong, Sijie Wang, Xiaohua Qian, Yue Li
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2026-03-01
Serija:	Frontiers in Immunology
Teme:	13-Valent pneumococcal conjugate vaccine immunogenicity infants safety Streptococcus pneumoniae
Online pristup:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1766313/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!